miR-424 and muscle wasting in pulmonary arterial hypertension

Benjamin Garfield (London, United Kingdom), Martin Connolly, Benjamin Garfield, Alexi Crosby, Peiran Yang, Nicholas Morrell, Michael Polkey, S. John Wort, Paul Kemp

Source: International Congress 2016 – Pulmonary hypertension: the clinic II
Session: Pulmonary hypertension: the clinic II
Session type: Thematic Poster
Number: 2412
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Benjamin Garfield (London, United Kingdom), Martin Connolly, Benjamin Garfield, Alexi Crosby, Peiran Yang, Nicholas Morrell, Michael Polkey, S. John Wort, Paul Kemp. miR-424 and muscle wasting in pulmonary arterial hypertension. Eur Respir J 2016; 48: Suppl. 60, 2412

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Quadriceps muscle fibre dysfunction in patients with pulmonary arterial hypertension
Source: Eur Respir J 2015; 45: 1737-1740
Year: 2015


IL-6 receptor overexpression in pulmonary arterial smooth muscle cells in idiopathic pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015

Peripheral and respiratory muscle strength in pulmonary artery hypertension
Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation
Year: 2012

Inspiratory muscle training in pulmonary hypertension
Source: Annual Congress 2013 –Rehabilitation, exercise and adjunct physiotherapy techniques in different respiratory conditions
Year: 2013

The role of growth and differentiation factor 15 (GDF-15) in the development of skeletal muscle wasting in pulmonary arterial hypertension (PAH)
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015

Muscle function and physical activity in patients with idiopathic pulmonary arterial hypertension (IPAH)
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014

Increased Cyr61 in pulmonary arterial hypertension involving in proliferation of pulmonary arterial smooth muscle cells
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016


Comparison of current therapies against endothelin-induced growth in pulmonary smooth arterial muscle cells (PASMCs) derived from patients with pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014


Influence of inspiratory muscle weakness in exercise capacity of patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: International Congress 2016 – Respiratory muscles and airways function: from physiology to clinical implications
Year: 2016


Impairment of respiratory muscle function in pulmonary hypertension
Source: Annual Congress 2007 - Clinical aspects of pulmonary arterial hypertension
Year: 2007




Peripheral arterial stiffness and endothelial dysfunction in pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Year: 2015

Anti-fibrotic effects of pirfenidone on pulmonary arterial vascular smooth muscle cells
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016

Smooth muscle microparticles as novel biomarkers of vascular remodelling and inflammation in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014

Impairment of skeletal muscle oxygen extraction and cardiac output are matched in precapillary pulmonary hypertension
Source: ERJ Open Res, 7 (3) 00449-2021; 10.1183/23120541.00449-2021
Year: 2021



Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease and coronary artery disease
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015


Is systemic oxygen extraction on exercise impaired in pulmonary arterial hypertension?
Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology
Year: 2013


Uric acid causes excessive pulmonary arterial smooth muscle cell proliferation via URATv1 upregulation in pulmonary arterial hypertension
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016

Quadriceps dysfunction in patients with pulmonary arterial hypertension
Source: Annual Congress 2007 - Pulmonary hypertension in the clinic
Year: 2007